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Shortly after Maiman successfully produced the first working
model of the ruby laser in 1960,
lasers were employed in the field
of ophthalmology. Ophthalmology
may, therefore, logically lay claim
to having introduced this ingenious
device as a therapeutic modality
into the medical armamentarium.
Actually, the discipline of ophthalmology has for almost a century
experimented with the idea of using
high intensity visible light for the
treatment of retinal pathology. This
idea became practical with the
epochal work of Meyer-Schwickerath (1959) and Littmann (1957)
who developed the well-known
Zeiss light coagulator. The laser,
therefore, may be considered simply
another energy source in light coagulation, a light source which, in
some instances, may be found superior to the xenon arc and, in
other instances, inferior.
The rapid progress of laser development requires constant reevaluation of its usefulness in the
field of medicine and, in particular,
the field of ophthalmology.
From the great number of existing lasers today, whether gaseous,
liquid or solid state, only five are
probably of ophthalmological interest at present. In regard to pulsed
lasers, i.e., those emitting light
within millisecond ranges, the ruby
and neodymium lasers must be
looked at critically, while in the
CW (continuous wave), the He-Ne
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(helium-neon) and argon gas lasers
are of importance. Special attention should be given to the
YAG-Nd (neodymium-doped, yttrium-aluminum-garnet) laser for
reasons outlined below.
The advantages, disadvantages,
as well as the potentials of these
lasers, will now briefly be discussed
and compared with the xenon arc
as a light source (Fig. 1) .
Ruby Laser (694.3 nm)

At present only the ruby laser
has been used clinically on a more
or less routine basis and here only
in the normal pulsed mode, i.e., a
pulse duration approximately 200
µsec to a few milliseconds. Extremely short exposure times of
nanosecond (10- 9 sec) or even
picosecond ranges ( 10- 12 sec) can
physically be achieved; however,
they have no place clinically and
may be extremely hazardous for the
ocular fundus. At these very short
exposure times high energies are
delivered so fast that effects other
than those caused by heat generation take place. For instance, shock
waves may be produced which may
cause explosion-like disruptions of
biological structures with intraocular hemorrhages and retinal detachment.
The principal advantage of the
ruby laser clinically is the emitted
monochromatic dark red light. This
spectral quality prevents photophobia, and the short exposure time
allows for ocular treatment without
anesthesia in most cases and treatment of areas close to the macula
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with less of a hazard. Some of the
disadvantages, however, have to do
with the same two factors which
are also classed as advantages. The
red light of the ruby laser is not
suitable for vascular lesions of the
ocular fundus, since the red blood
vessels, aneurysms or vascular
tumors reflect the light to a great
extent where absorption is needed
for effective treatment. In addition,
the very short exposure times make
it necessary for the intended intensity of the exposure beam to be
preset. Once the triggering button
is pushed, all the energy impinging
on the eye will interact with the exposed ocular structures without further adjustments being made during
this exposure time. This fact was
responsible for severe overexposures
with subretinal, intraretinal, and
even preretinal hemorrhages when
lasers were first used clinically in
ophthalmology. Even today this
complicating factor may still be a
considerable one where the operator is inexperienced. Another
disadvantage of the laser burn is
that sharply demarcated coagulation spots produced by lasers are at

times less desirable clinically than
those with a wider reactive zone,
decreasing in intensity toward the
periphery of the lesion ( Geeraets
et al., 1965; Geeraets, 1965) .
Neodymium Laser (1060 nm)

A theoretical advantage of this
laser lies in the fact that the beam
is invisible to the eye. Exposure
times correspond to those of the
ruby laser. Clinically its great disadvantage in ophthalmology is the
high absorption of its beam energy
within the ocular media (Geeraets
and Berry, 1968). The total amount
of energy necessary to produce a
chorioretinal lesion comparable to
that produced by a ruby laser is
five to ten times as great as the
energy required with the ruby laser
( Geeraets, 1967) .
Investigations on the effect of
neodymium and ruby lasers on nonpigmented and pigmented experimental retinal or choroidal tumors
indicated that both light sources
failed to completely destroy the
tumor masses. Tumor cells continued to show undisturbed growth
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Fig. I-Spectral position of light emitted from various laser sources in comparison with emission characteristics of a xenon high pressure light source.
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in cell cultures after maximum exposures to these laser light sources
(Unpublished data) , and most of
the cells appeared also histologically
unaltered in morphology. This latter observation was also described
by Chan, Guerry, and Geeraets
( 1963) following treatment with
the xenon arc as a light source.
High intensity exposures with the
neodymium laser or fast repetition
of such exposures have led to cataract formation and to extensive
biomicroscopically visible vitreous
clouding and electrophoreticallydemonstrable protein changes in
the vitreous (Geeraets, 1966; Berry,
Lederman and Geeraets, 1968).
He-Ne Laser (632 .8 nm)

This laser, which emits a bright
red colored light beam, belongs to
the CW gas lasers. Its emission
appears more intense to the human
eye than does the deep red light of
the ruby laser. Its greatest advantage lies in the greater variability
of possible exposure times. For the
production of chorioretinal lesions,
exposure times may be chosen from
millisecond ranges up to any desired length, thus combining positive features of the ruby laser and
the xenon arc. For long exposure
times, however, it would be preferable or necessary in most instances
to administer retrobulbar anesthesia.
At present, the greatest disadvantage of this laser is the great length
and weight of the instrument required to obtain adequate power
output if one wishes to achieve the
great range of exposure times. Experimentally this has been solved
by delicately counterbalancing the
instrument. The use of fiber optics,
though decreasing the power output, may reduce this disadvantage.
Argon Laser (Major Output at
Wave Lengths 488 nm
and 515 nm)

This laser emits numerous wave
lengths from the ultraviolet region
to the blue-green spectrum with the
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latter as the most intense emissions.
From a theoretical point of view,
this laser has a number of advantages. The transmission of these
wave lengths through the ocular
media is almost 95 °, and they fall
in the region of peak absorption by
the retinal pigment epithelium and
hemoglobin ( Geeraets et al., 1962) .
The output energy of this laser is
greater than that of the He-Ne
laser, which means that the exposure times can be chosen by the
surgeon to fit the optimal needs of
a given situation. As of now the
greatest disadvantages of this laser
for clinical ophthalmological use
are its bulkiness and the high purchase price. Experimentally this
laser has given promising results.
Exposures are best done under retrobulbar anesthesia unless very
short exposure times (ms ranges)
are used.
YAG-Nd Laser (1064 nm)

Though the primary wave length
of this solid-state laser is very close
to that of the neodymium laser,
the YAG-Nd laser seems to be
capable, experime •1tally, of having
sufficient energy i,' its second harmonic is used , i.e'. , frequency doubling. This can be achieved by passing the primary laser beam through
a barium-sodium-niobate crystal
(B,NaNb,,O" ) . In this way the
wave length obtained is 532 nm.
The exit energy at the 532 nm
wave length seems, experiment·
ally, to be sufficiently great to
give a flexibility in exposure time
selection even greater than that described for the He-Ne and argon
lasers. This laser seems to be
unique in this respect, since it can
be pulsed or used in Q-switched
fashion similar to the ruby and
neodymium lasers as well as on a
CW mode similar to most gas lasers.
Its dimensions and weight are
significantly less than those of the
two gas lasers mentioned above.
The emitted wave length of green
color would theoretically be somewhat less advantageous than that of

the argon laser (about 12 % of the
light incident on the cornea is absorbed by the hemoglobin [Geeraets
et al. , 1962]) . However, the other
features described lead one to believe that this more recent laser
development may present a light
source possibly of some potential
for use in clinical ophthalmology.

Xenon High Pressure Light
Coagulator (Zeiss-Spectral
Range 350- 1100 nm)

This instrument has had universal clinical acceptance with its
usefulness documented by the successful treatment of thousands of
patients all over the world (MeyerS ch wicker a th , 1959; Guerry,
1968). Its greatest advantage is
that of adjustable exposure time.
The standard commercially available instrument allows the operator
to select exposure times by pushbutton operation while making it
possible to observe the area under
treatment as the actual exposure
takes place. This permits the operator to terminate the exposure at any
time he deems advisable. An optional accessory is a built-in shutter, which allows exposure times
down to 20 msec. In most cases
retrobulbar anesthesia is advisable.
This factor is really not a disadvantage as has been claimed by some
advocates of the ruby laser, for it
allows one more easily to manipulate the globe by forceps. This feature is of particular value where
the extreme temporal periphery is
to be treated or where the globe
to be treated is relatively enophthalmic.
A disadvantage claimed by some
is that a portion of the emitted
spectrum is in the near infrared.
Though this spectral range has as
high an absorption rate by the
ocular media as does the neodymium wave length, one should realize
that, in the latter instance, this is
the only wave length emitted, while
in the xenon light coagulator the
greatest spectral portion lies in the

visible range with a high transmission through the ocular media up to
95 % (Geeraets et al., 1960, 1962).
When properly used , i.e. , not too
rapid exposure and avoidance of
overexposures, this coagulator apparently gives rise to no ill effects
attributable to these spectral emission characteristics, a general observation based on more than ten years
of experience since its introduction
into clinical ophthalmology. If one
wishes to eliminate these theoretical disadvantages, a Schott KG III
heat-absorbing filter can be inserted
within the optical pathway of this
coagulator. This eliminates the near
infrared beyond 900 nm almost
entirely from the exit beam. In
some instances, where lesions close
to the macula must be treated,
shorter exposure times than those
obtainable with the Zeiss coagulator
would be of advantage. Experimentally this has been achieved by
pulsing the xenon high pressure
lamp via a capacitor bank (Ham
et al. , 1963). These short pulses
simulate the exposure times of the
ruby laser. Broad-base interference
filters used with this coagulator also
provide a means of comparing the
effects of various spectral regions.

Conclusion

The continuing evaluation of
laser instrumentation is of particular interest to the ophthalmologist.
Several lasers now exhibit potential
properties which may result in superior clinical instruments in the
future.
An important feature of almost
all existing lasers, as related to
ophthalmology, is the potential hazard of accidental exposure of the
eye. This aspect of the laser is certainly as important as its clinical
application, and it should be the
responsibility of ophthalmologists
to work actively to provide recommendations for safety standards
and criteria for ocular protection
in every field of laser application.
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